このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Comparison of Motor Relearning Program and Electric Muscle Stimulation in Subacute Stroke Patients (MORE-EMS)

2026年7月18日 更新者:Montiha Azeem

Stroke is one of the leading causes of long-term disability worldwide, with upper limb motor impairment being a common consequence that limits independence in activities of daily living. The Motor Relearning Program (MRP) is a task-oriented rehabilitation approach designed to improve motor recovery through repetitive functional practice. Electrical Muscle Stimulation (EMS) may further enhance muscle activation and facilitate motor recovery when combined with conventional rehabilitation.

The purpose of this single-blinded randomized controlled trial is to compare the effectiveness of the Motor Relearning Program combined with Electrical Muscle Stimulation versus the Motor Relearning Program alone in improving upper limb function in individuals with subacute stroke. Thirty-six eligible participants with subacute stroke will be randomly allocated into two groups. Group A will receive MRP together with EMS, while Group B will receive the same MRP without EMS. Both groups will undergo treatment for 1 hour per day, 5 days per week, for 6 weeks.

Upper limb motor recovery and muscle tone will be evaluated at baseline and after the intervention using the Upper Extremity Fugl-Meyer Assessment (UEFMA), Modified Ashworth Scale (MAS), and Motor Evaluation Scale for Upper Extremity in Stroke (MESUPES). The findings of this study may help determine whether adding EMS to a structured Motor Relearning Program provides greater improvements in upper limb function than MRP alone in individuals with subacute stroke.

調査の概要

詳細な説明

Stroke frequently results in upper limb motor impairment, reduced functional independence, and diminished quality of life. Despite advances in stroke rehabilitation, recovery of upper extremity function remains challenging. The Motor Relearning Program (MRP) is a task-oriented rehabilitation approach that promotes neuroplasticity through repetitive practice of meaningful functional activities. Electrical Muscle Stimulation (EMS) has been proposed as an adjunctive intervention to facilitate voluntary muscle activation, improve neuromuscular recruitment, and enhance functional recovery.

This study is designed as a single-center, single-blinded, randomized controlled trial conducted at the University of Lahore Teaching Hospital. A total of 36 participants with subacute stroke who meet the eligibility criteria will be recruited and randomly allocated into two equal groups using the sealed envelope randomization technique.

Participants in Group A will receive a structured Motor Relearning Program combined with Electrical Muscle Stimulation. The intervention will include repetitive task-oriented upper limb activities such as opening and closing bottle lids, lifting and drinking from a glass, arranging puzzles, reaching in different directions, transferring small objects, turning door handles, and turning book pages. EMS will be applied to the affected upper limb muscles, including the deltoid, biceps brachii, triceps brachii, wrist flexors and extensors, and finger flexors and extensors, using surface electrodes for 10 minutes during each treatment session.

Participants in Group B will receive the identical Motor Relearning Program without Electrical Muscle Stimulation. Both groups will receive treatment for 1 hour per day, 5 days per week, for 6 consecutive weeks, with progression of task difficulty according to individual performance.

Outcome assessments will be performed at baseline and after completion of the 6-week intervention. The primary outcome measures are the Upper Extremity Fugl-Meyer Assessment (UEFMA) and the Modified Ashworth Scale (MAS). The secondary outcome measure is the Motor Evaluation Scale for Upper Extremity in Stroke (MESUPES). These validated outcome measures will be used to evaluate motor recovery, upper limb function, and muscle tone.

The study aims to determine whether the addition of Electrical Muscle Stimulation to a Motor Relearning Program produces superior improvements in upper limb motor function compared with the Motor Relearning Program alone in individuals with subacute stroke. The results may contribute evidence to support the development of effective rehabilitation strategies for upper limb recovery following stroke.

研究の種類

介入

入学 (推定)

36

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Punjab Province
      • Lahore、Punjab Province、パキスタン、54000
        • 募集
        • Shadman Medical Center, Lahore
        • コンタクト:
        • コンタクト:
        • 主任研究者:
          • Laraib Gull, MSPTN

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Age 40-65 years
  • Both male and female
  • Sub acute stroke patients diagnosed by neurologist
  • Motor assessment scale score 2-3
  • Subjects able to sit for 30 secs without using upper extremities for support.
  • Modified Ashworth scale value < 2

Exclusion Criteria:

  • Patients with Mini Mental State Examination <23
  • Cognitive disorders and perceptual disorders
  • Any musculoskeletal disorders
  • Severe cardiac diseases

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:group A Motor Relearning Program + Electrical Muscle Stimulation
Participants will receive a Motor Relearning Program combined with Electrical Muscle Stimulation (EMS). The Motor Relearning Program will consist of task-oriented upper limb activities for 1 hour per session, 5 days per week, for 6 weeks. EMS will be applied to the affected upper limb muscles for 10 minutes during each treatment session.
Electrical Muscle Stimulation will be applied to the affected upper limb muscles, including the deltoid, biceps brachii, triceps brachii, wrist flexors and extensors, and finger flexors and extensors, using surface electrodes for 10 minutes during each treatment session. Stimulation intensity will be adjusted to produce visible, pain-free muscle contractions according to participant tolerance. EMS will be administered in combination with the Motor Relearning Program, 5 days per week for 6 weeks.
アクティブコンパレータ:group B Motor Relearning Program
Participants will receive the same Motor Relearning Program consisting of task-oriented upper limb exercises for 1 hour per session, 5 days per week, for 6 weeks, without Electrical Muscle Stimulation.
Participants will receive a structured Motor Relearning Program consisting of repetitive task-oriented upper limb activities, including reaching, grasping, object manipulation, lifting, puzzle arrangement, and functional daily living tasks. Therapy will be provided for 1 hour per session, 5 days per week, for 6 weeks, with progressive increases in task difficulty according to participant performance.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Upper Extremity Fugl-Meyer Assessment (UEFMA)
時間枠:Baseline and Week 6
The UEFMA will be used to assess upper limb motor recovery following the intervention. Scores obtained at baseline and after the 6-week intervention will be compared between the two study groups to evaluate changes in upper extremity motor function.
Baseline and Week 6

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Laraib Gull, MSPTN、The University of Lahore, Lahore

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年9月6日

一次修了 (推定)

2026年9月6日

研究の完了 (推定)

2026年9月6日

試験登録日

最初に提出

2026年7月18日

QC基準を満たした最初の提出物

2026年7月18日

最初の投稿 (実際)

2026年7月22日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月22日

QC基準を満たした最後の更新が送信されました

2026年7月18日

最終確認日

2026年7月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する